Diagnostic Pathology · 2012 · 60 citations · 19 references
MedicineOncologyPathologyBreast OncologyGene ExpressionMolecular OncologyCancer BiomarkersCancer TranscriptomicsMicrorna BiologyMolecular Tumor ProfilingNoncoding Rna In CancerTranscriptomic ProfilingDisease-free Survival AnalysisDisease-free Survival AssessmentMicrorna BiomarkersMicrorna In CancerMicrorna Prognostic MarkersPredictive BiomarkersPrognostic BiomarkersPrognostic Rna Biomarkers
BACKGROUND: Breast cancer is the most common malignancy with the highest incidence rates among women worldwide. Triple-negative breast cancer (TNBC) represents the major phenotype of basal-like molecular subtype of breast cancer, characterized by higher incidence in young women and a very poor prognosis. MicroRNAs (miRNAs) are small non-coding RNAs playing significant role in the pathogenesis of many cancers including breast cancer. Therefore, miRNAs are also potential prognostic and/or predictive biomarkers in triple-negative breast cancer patients. METHODS: Thirty-nine TNBC patients with available formalin-fixed paraffin-embedded (FFPE) tissues were enrolled in the study. MiR-34a, miR-34b, and miR-34c were analyzed using qRT-PCR and correlated to clinico-pathological features of TNBC patients. RESULTS: Expression levels of miR-34b significantly correlate with disease free survival (DFS) (p = 0.0020, log-rank test) and overall survival (OS) (p = 0.0008, log-rank test) of TNBC patients. No other significant associations between miR-34a, miR-34b, and miR-34c with available clinical pathological data were observed. CONCLUSIONS: MiR-34b expression negatively correlates with disease free survival and overall survival in TNBC patients. Thus, miR-34b may present a new promising prognostic biomarker in TNBC patients, but independent validations are necessary.
19
A microRNA component of the p53 tumour suppressor network
Lin He, Xingyue He, Lee P. Lim et al. · Nature · 2007 · 2.7K citations
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc, Maggie C.U. Cheang, Scott Tyldesley et al. · Journal of Clinical Oncology · 2010 · 1.2K citations
Medicine, Cancer Biology, Oncology +14
MiR-34, SIRT1, and p53: The feedback loop
Munekazu Yamakuchi, Charles J. Lowenstein · Cell Cycle · 2009 · 462 citations · Full text
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
David C. Corney, Chang‐Il Hwang, Andrés Matoso et al. · Clinical Cancer Research · 2010 · 308 citations · Full text